Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cardiovascular Diseases × Raloxifene Hydrochloride × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Osteoporosis 1 Cardiovascular Diseases 1

Interventions

palbociclib 2 Blood Pressure 2 xinmailong 1 ribociclib 1 abemaciclib 1 Social Determinants of Health 1 Rivaroxaban 1 Restraint, Physical 1 Raloxifene Hydrochloride 1 Quality of Life 1 Progesterone 1 Positron-Emission Tomography 1 Patient Navigation 1 Linseed Oil 1 High-Intensity Interval Training 1 Heart Rate 1 Heart Function Tests 1 Genetic Testing 1 Exercise 1 Estradiol 1 Anthracyclines 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00190593 2007-01-26

Raloxifene Use for The Heart

Eli Lilly and Company

Phase 3 Completed

10,000 enrolled

Breast Neoplasms, Cardiovascular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡